Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
04/2005
04/07/2005US20050075394 Phenethanolamine derivatives for treatment of respiratory diseases
04/07/2005US20050075377 Compounds for elevating plasma lipid levels with prodrugs for humans and other mammals
04/07/2005US20050075374 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
04/07/2005US20050075367 Ester compound and medicinal use thereof
04/07/2005US20050075320 Gamma-secretase inhibitors
04/07/2005US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials
04/06/2005EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy
04/06/2005EP1519916A1 Heat sensitive recording material
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
04/06/2005EP1334086B1 Phenoxyphenyl alkane sulfonates
04/06/2005EP1246796B1 Process for the preparation of diphenyl ether compounds
04/06/2005CN1604890A 取代的环己烷衍生物 Substituted cyclohexane derivatives
04/06/2005CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds
04/06/2005CN1195735C Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases
04/06/2005CN1195732C Substituted sulfonyl aminomethyl benzoic acid (derivatives) and method for production thereof
04/06/2005CN1195524C Use of benzenesulfonyl (thio) ureas in combination with beta-receptor retarder for treatment and prophylaxis of dysfunctions of autonomous nervous system
04/05/2005US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family
04/05/2005US6875760 Glucagon antagonists/inverse agonists
04/05/2005CA1341478C Therapeutic methods using catalytic antibodies
03/2005
03/31/2005WO2005028516A2 Albumin-binding derivatives of therapeutic peptides
03/31/2005WO2005028427A1 Aminoalkylamide substituted cyclohexyl derivatives
03/31/2005WO2005028426A1 Novel 4-phenylamino-benzaldoxime derivative and use thereof as mek inhibitor
03/31/2005WO2005027837A2 Substituted sulfonamides
03/31/2005WO2004073606A3 Sulfonamide derivatives as ppar modulators
03/31/2005US20050070582 For example,1-{[2-(3,5-dimethylphenoxy)-5-nitrophenyl]sulfonyl}-4-ethylpiperazine or 1-{[2-(3,5-dichlorophenoxy)-5-nitrophenyl]sulfonyl}piperazine; for the treatment of asthma, atopic dermatitis, allergic rhinitis and other inflammatory/immunological disorders
03/31/2005US20050070485 Phenylalanine derivatives
03/31/2005CA2539165A1 Cinnamoyl compound and use of the same
03/31/2005CA2539159A1 Aminoalkylamide substituted cyclohexyl derivatives
03/31/2005CA2538291A1 Substituted sulfonamides
03/30/2005EP1517889A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
03/30/2005EP1517887A1 N-sulphonylaminoacetonitriles having pesticidal properties
03/30/2005EP1517680A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/29/2005US6872852 Polyamine analogues as cytotoxic agents
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/24/2005WO2005027157A2 Salt fusible at ordinary temperature and electrochemical device
03/24/2005WO2005026134A1 Organic compounds
03/24/2005WO2005025557A1 An agent for plasminogen-activation and matrix metalloproteinase associated conditions and methods of use
03/24/2005WO2005025554A2 Dipeptidyl peptidase iv inhibitor
03/24/2005WO2005012220A3 Cycloalkylidene compounds as modulators of estrogen receptor
03/24/2005WO2004087623A3 An improved process for the preparation of (r) (-) tamsulosin hydrochloride
03/24/2005WO2004072101A3 Phenylglycine derivatives useful as serine protease inhibitors
03/24/2005US20050065346 anticoagulants; thrombosis; factor x inhibitor
03/24/2005US20050065210 Anticholesterol agents; antilipemic agents; arteriosclerosis; cardiovascular disorders; parasiticides; antitumor agents; antiproliferative agents; antidiabetic agents
03/24/2005US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases
03/24/2005CA2539016A1 Organic compounds
03/23/2005EP1517181A1 Sulfonamide compound, polymer compound, reist material and pattern formation method
03/23/2005EP1515947A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament
03/23/2005EP1515944A1 Aspartyl protease inhibitors
03/23/2005EP1515941A1 2-naphthamide derivatives
03/23/2005EP1515940A2 Aminoalkoxy-functional chalcones
03/23/2005EP1028949B1 Carbamoylphenylsulfonyl ureas, method for their production and their application as herbicides and plant growth regulators
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6869951 Such as N-(2-(4-morphoolinyl)ethyl)-N-((4-((4-pentyl-benzoyl)amino)phenyl)sulfonyl) -D-valine; for treatment of osteoarthritis
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/17/2005WO2005023831A1 Detection of cholesterol ozonation products
03/17/2005WO2005023242A1 Entry inhibitors of the hiv virus
03/17/2005WO2004096120A3 Compounds that selectively bind to membranes of apoptotic cells
03/17/2005WO2004083867A3 Modulators of g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
03/17/2005US20050059842 Reacting diamine with sulfonyl halide of water, solvent and base; sulfonamidation, salt formation; hydrogenation catalysts; metallization
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059713 Antiviral agents for the treatment, preventions, or amelioration of viral infections; for example, 3-Biphenyl-4-yl-(2S)-[(3'-chloro-4'-fluoro-4-hydroxy-biphenyl-3-carbonyl)-amino]-propionic acid methyl ester
03/17/2005US20050059712 Immunosuppressants for treating skin disorders, acne, alopecia, estrogen- or androgen-dependent tumors, rheumatoid arthritis, type I and II diabetes, lupus erythematosus, multiple sclerosis, ulcerative colitis, Crohn's disease, psoriasis, contact dermatitis, graft versus host disease, eczema, asthma
03/17/2005US20050059705 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants
03/17/2005US20050059611 such as 3-{4-[1-(4-Cyclohex-1-enylphenyl)-3-(3,5-dichlorophenyl)ureidomethyl]benzoylamino}-2,2-difluoropropionic acid), used for treatment and/or prevention of hyperglycemia, diabetes, lipid metabolism disorders and obesity
03/17/2005US20050058935 Sulfonamide compound, polymer compound, resist material and pattern formation method
03/17/2005CA2537984A1 Detection of cholesterol ozonation products
03/16/2005EP1513802A1 Alpha-sulfonylamino-acetonitriles
03/16/2005EP1513795A2 Propionic acid derivatives and their use as hppars activators
03/16/2005EP1355894B1 Amidinophenylalanine derivatives as thrombin inhibitors
03/16/2005EP1311476B1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
03/16/2005EP0874625B1 Indane derivatives for antipsychotic compositions
03/16/2005CN1593937A Thermosensitive recording materials
03/16/2005CN1593430A Method for preparing sulfonamide compound liposome and its formulation
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867284 Fluorinated oligopeptides especially those having 4,4-difluoro- 2-amino butyric acid at the C terminus
03/15/2005US6867214 Quinazoline derivatives and pharmaceutical applications thereof
03/15/2005US6867208 Vitronectin receptor antagonists, their preparation and their use
03/10/2005WO2005021490A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2005000795A3 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
03/10/2005US20050054883 1-hydroxy-1-(5-norbornene-2-yl)-2,2,4,4,4-pentafluorobutane-3-one; 1-(5-norbornene-2-yl)-2,2,4,4,4-pentafluorobutane-1,3,3-triol; excellent in transparency to irradiation, dry etching resistance, has low hydrophobicity, excellent in development characteristics, useful for photoresist resin
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054641 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
03/10/2005US20050054528 Thermosensitive recording materials
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1512545A1 Thermosensitive recording materials
03/09/2005EP1511722A1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
03/09/2005EP1511473A2 Bis-aromatic alkanols
03/09/2005EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/09/2005EP1345892B1 Acylaminoalkyl-substituted benzenesulfonamide derivatives
03/09/2005CN1590375A TNF-alpha prodn. inhibitors
03/09/2005CN1590374A TNF-alpha prodn. inhibitors
03/09/2005CN1192035C Inhibitors of interleukin-1'beta' converting enzyme
03/09/2005CN1192015C Cell adhesion inhibitors
03/08/2005US6864392 α-Sulfin and α-Sulfonamino amide derivatives
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864254 Kidney diosrders; brain disorders
03/08/2005US6863838 Low melting point
03/03/2005WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase
1 ... 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 ... 177